Cell Death and Heart Failure in Obesity: Role of Uncoupling Proteins

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Ruiz Ramírez, Angélica ^a   López Acosta, Ocarol ^a   Barrios Maya, Miguel Angel ^a   El Hafidi, Mohammed ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CARDIOLOGY; CELL DEATH; CELL MEMBRANES; HEART; MAMMALS; METABOLISM; MITOCHONDRIA; NUTRITION; TISSUE;

APOPTOTIC CELL DEATH; CARDIOMYOCYTE SURVIVAL; METABOLIC SYNDROMES; MITOCHONDRIAL MEMBRANES; PATHOLOGICAL PROCESS; PROGRAMMED CELL DEATHS; REACTIVE OXYGEN SPECIES; RESPIRATORY COMPLEX;

PROTEINS;

FATTY ACID; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

BIOENERGY; CARDIAC MUSCLE CELL; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; DOWN REGULATION; FATTY ACID OXIDATION; GENETIC REGULATION; HEART FAILURE; HEART PROTECTION; HOMEOSTASIS; HUMAN; LIPOTOXICITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; OBESITY; REVIEW; CARDIAC MUSCLE; CYTOLOGY; LIPID PEROXIDATION; METABOLISM; MITOCHONDRION; PATHOLOGY;

CELL DEATH; CELL SURVIVAL; HEART FAILURE; HUMANS; LIPID PEROXIDATION; MITOCHONDRIA; MITOCHONDRIAL UNCOUPLING PROTEINS; MYOCARDIUM; REACTIVE OXYGEN SPECIES;

EID: 84985952051     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/9340654     Document Type: Review

References (116)

1. M. Kankaanpää, H.-R. Lehto, J. P. Pärkkä et al., "Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serumfree fatty acid levels, "The Journal of Clinical Endocrinology &Metabolism, vol. 91, no. 11, pp. 4689-4695, 2006.
2. D. Joel, "The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise schilling, " Antioxidants & Redox Signaling, vol. 22, no. 17, pp. 1515-1526, 2015.
3. K. R. Laskowski and R. R. Russell III, "Uncoupling proteins in heart failure, " Current Heart Failure Reports, vol. 5, no. 2, pp. 75-79, 2008.
4. O. J. Rider, P. Cox, D. Tyler, K. Clarke, and S. Neubauer, "Myocardial substrate metabolism in obesity, " International Journal of Obesity, vol. 37, no. 7, pp. 972-979, 2013.
5. A. J. Murray, R. E. Anderson, G. C. Watson, G. K. Radda, and K. Clarke, "Uncoupling proteins in human heart, " The Lancet, vol. 364, no. 9447, pp. 1786-1788, 2004.
6. P. Ježek and L. Hlavatá, "Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism, " International Journal of Biochemistry and Cell Biology, vol. 37, no. 12, pp. 2478-2503, 2005.
7. A. J. Kowaltowski, N. C. de Souza-Pinto, R. F. Castilho, and A. E. Vercesi, "Mitochondria and reactive oxygen species, " Free Radical Biology and Medicine, vol. 47, no. 4, pp. 333-343, 2009.
8. E. Cadenas and K. J. A. Davies, "Mitochondrial free radical generation, oxidative stress, and aging, " Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 222-230, 2000.
9. S. Liu, B. Geng, L. Zou et al., "Development of hypertrophic cardiomyopathy in perilipin-1 null mice with adipose tissue dysfunction, " Cardiovascular Research, vol. 105, no. 1, pp. 20-30, 2015.
10. G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley, "Myocardial fatty acid metabolism in health and disease, " Physiological Reviews, vol. 90, no. 1, pp. 207-258, 2010.
11. C. Toda and S. Diano, "Mitochondrial UCP2 in the central regulation of metabolism, " Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 28, no. 5, pp. 757-764, 2014.
12. V. J. Victorino, A. L. Mencalha, and C. Panis, "Post-translational modifications disclose a dual role for redox stress in cardiovascular pathophysiology, " Life Sciences, vol. 129, pp. 42-47, 2015.
13. S. Cardoso, S. Correia, C. Carvalho et al., "Perspectives on mitochondrial uncoupling proteins-mediated neuroprotection, " Journal of Bioenergetics and Biomembranes, vol. 47, no. 1-2, pp. 119-131, 2014.
14. R. J. Mailloux and M.-E. Harper, "Mitochondrial proticity and ROS signaling: lessons fromthe uncoupling proteins, " Trends in Endocrinology andMetabolism, vol. 23, no. 9, pp. 451-458, 2012.
15. S. Collins, J. Pi, and E. Yehuda-Shnaidman, "Uncoupling and reactive oxygen species (ROS)-a double-edged sword for β-cell function? 'moderation in all things', " Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 26, no. 6, pp. 753-758, 2012.
16. K.-U. Lee, I. K. Lee, J. Han et al., "Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis, " Circulation Research, vol. 96, no. 11, pp. 1200-1207, 2005.
17. X. Jin, Z. Xiang, Y.-P. Chen, K.-F. Ma, Y.-F. Ye, and Y.-M. Li, "Uncoupling protein and nonalcoholic fatty liver disease, " Chinese Medical Journal, vol. 126, no. 16, pp. 3151-3155, 2013.
18. C. Ozcan, M. Palmeri, T. L. Horvath, K. S. Russell, and R. R. Russell III, "Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 9, pp. H1192-H1200, 2013.
19. C. Perrino, G. G. Schiattarella, A. Sannino et al., "Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure, " Journal of the American Heart Association, vol. 2, no. 3, Article ID e000086, 2013.
20. G. Petrosillo, F. M. Ruggiero, and G. Paradies, "Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria, " The FASEB Journal, vol. 17, no. 15, pp. 2202-2208, 2003.
21. J. Jiang, Z. Huang, Q. Zhao, W. Feng, N. A. Belikova, and V. E. Kagan, "Interplay between bax, reactive oxygen species production, and cardiolipin oxidation during apoptosis, " Biochemical and Biophysical Research Communications, vol. 368, no. 1, pp. 145-150, 2008.
22. C.-C. Wu and S. B. Bratton, "Regulation of the intrinsic apoptosis pathway by reactive oxygen species, " Antioxidants & Redox Signaling, vol. 19, no. 6, pp. 546-558, 2013.
23. D. Ricquier and F. Bouillaud, "The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP, " The Biochemical Journal, vol. 345, no. 2, pp. 161-179, 2000.
24. M. J. Berardi, W. M. Shih, S. C. Harrison, and J. J. Chou, "Mitochondrial uncoupling protein 2 structure determined by NMRmolecular fragment searching, " Nature, vol. 476, no. 7358, pp. 109-113, 2011.
25. T. Hoang, T. Matovic, J. Parker, M. D. Smith, and M. Jelokhani-Niaraki, "Role of positively charged residues of the second transmembrane domain in the ion transport activity and conformation of human uncoupling protein-2, " Biochemistry, vol. 54, no. 14, pp. 2303-2313, 2015.
26. A. Ledesma, M. García de Lacoba, and E. Rial, "The mitochondrial uncoupling proteins, " Genome Biology, vol. 3, no. 12, article 3015, 2002.
27. D. G. Nicholls, "A history of UCPI, " Biochemical Society Transactions, vol. 29, part 6, pp. 751-755, 2001.
28. Z. B. Andrews, S. Diano, and T. L. Horvath, "Mitochondrial uncoupling proteins in the CNS: in support of function and survival, " Nature Reviews Neuroscience, vol. 6, no. 11, pp. 829-840, 2005.
29. A. M. Woyda-Ploszczyca and W. Jarmuszkiewicz, "Different effects of guanine nucleotides (GDP and GTP) on proteinmediated mitochondrial proton leak, " PLoS ONE, vol. 9, no. 6, Article ID e98969, 2014.
30. J. Jiménez-Jiménez, A. Ledesma, P. Zaragoza, M. M. González-Barroso, and E. Rial, "Fatty acid activation of the uncoupling proteins requires the presence of the central matrix loop from UCP1, " Biochimica et Biophysica Acta-Bioenergetics, vol. 1757, no. 9-10, pp. 1292-1296, 2006.
31. K. S. Echtay, M. P. Murphy, R.A. J. Smith, D.A. Talbot, and M.D. Brand, "Superoxide activatesmitochondrial uncoupling protein 2 fromthe matrix side. Studies using targeted antioxidants, " The Journal of Biological Chemistry, vol. 277, no.49, pp.47129-47135, 2002.
32. K. S. Echtay, D. Roussel, J. St-Plerre et al., "Superoxide activates mitochondrial uncoupling proteins, " Nature, vol. 415, no. 6867, pp. 96-99, 2002.
33. S. Cadenas, J. A. Buckingham, S. Samec et al., "UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged, " The FEBS Letters, vol. 462, no. 3, pp. 257-260, 1999.
34. N. E. Buroker, M. E. Young, C. Wei et al., "The dominant negative thyroid hormone receptor β-mutant Δ337T alters PPARΔ signaling in heart, " American Journal of Physiology- Endocrinology and Metabolism, vol. 292, no. 2, pp. E453-E460, 2007.
35. S. Krauss, C.-Y. Zhang, and B. B. Lowell, "The mitochondrial uncoupling-protein homologues, " Nature Reviews Molecular Cell Biology, vol. 6, no. 3, pp. 248-261, 2005.
36. M. Zhang, B. Wang, Y.-H. Ni et al., "Overexpression of uncoupling protein 4 promotes proliferation and inhibits apoptosis and differentiation of preadipocytes, " Life Sciences, vol. 79, no. 15, pp. 1428-1435, 2006.
37. S. L. Chan, D. Liu, G. A. Kyriazis, P. Bagsiyao, X. Ouyang, and M. P. Mattson, "Mitochondrial uncoupling protein-4 regulates calcium homeostasis and sensitivity to store depletion-induced apoptosis in neural cells, " Journal of Biological Chemistry, vol. 281, no. 49, pp. 37391-37403, 2006.
38. A. T. Akhmedov, V. Rybin, and J. Marín-García, "Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart, " Heart Failure Reviews, vol. 20, no. 2, pp. 227-249, 2015.
39. S. J. F. Chong, I. C. C. Low, and S. Pervaiz, "Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS regulator, " Mitochondrion, vol. 19, pp. 39-48, 2014.
40. A. Vozza, G. Parisi, F. De Leonardis et al., "UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 3, pp. 960-965, 2014.
41. C. Pecqueur, T. Bui, C. Gelly et al., "Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization, " The FASEB Journal, vol. 22, no. 1, pp. 9-18, 2008.
42. C. J. McLeod, A. Aziz, R. F. Hoyt Jr., J. P. McCoy Jr., and M. N. Sack, "Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia, " Journal of Biological Chemistry, vol. 280, no. 39, pp. 33470-33476, 2005.
43. Y. Teshima, M. Akao, S. P. Jones, and E. Marbán, "Uncoupling protein-2 overexpression inhibitsmitochondrial death pathway in cardiomyocytes, " Circulation Research, vol. 93, no. 3, pp. 192-200, 2003.
44. X.-B. Ji, X.-R. Li, D. Hao et al., "Inhibition of uncoupling protein 2 attenuates cardiac hypertrophy induced by transverse aortic constriction in mice, " Cellular Physiology and Biochemistry, vol. 36, no. 5, pp. 1688-1698, 2015.
45. W. Cao, A. V. Medvedev, K. W. Daniel, and S. Collins, "β-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase, " The Journal of Biological Chemistry, vol. 276, no. 29, pp. 27077-27082, 2001.
46. F. Villarroya, R. Iglesias, and M. Giralt, "PPARs in the control of uncoupling proteins gene expression, " PPAR Research, vol. 2007, Article ID 74364, 12 pages, 2007.
47. M. J. Barberá, A. Schlüter, N. Pedraza, R. Iglesias, F. Villarroya, and M. Giralt, "Peroxisome proliferator-activated receptor α activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell, " The Journal of Biological Chemistry, vol. 276, no. 2, pp. 1486-1493, 2001.
48. N. Pedraza, M. Rosell, J. Villarroya et al., "Developmental and tissue-specific involvement of peroxisome proliferatoractivated receptor-α in the control of mouse uncoupling protein-3 gene expression, " Endocrinology, vol. 147, no. 10, pp. 4695-4704, 2006.
49. A. Bugge, M. Siersbæk, M. S. Madsen, A. Göndör, C. Rougier, and S. Mandrup, "A novel intronic peroxisome proliferatoractivated receptor γ enhancer in the Uncoupling Protein (UCP) 3 gene as a regulator of both UCP2 and-3 expression in adipocytes, " Journal of Biological Chemistry, vol. 285, no. 23, pp. 17310-17317, 2010.
50. F. Baraldi, F. Dalalio, B. Teodoro, I. Prado, C. Curti, and L. Alberici, "Body energy metabolism and oxidative stress in mice supplemented with conjugated linoleic acid (CLA) associated to oleic acid, " Free Radical Biology and Medicine, vol. 75, supplement 1, p. S21, 2014.
51. G. Solanes, N. Pedraza, R. Iglesias, M. Giralt, and F. Villarroya, "Functional relationship between myod and peroxisome proliferator-activated receptor-dependent regulatory pathways in the control of the human uncoupling protein-3 gene transcription, " Molecular Endocrinology, vol. 17, no. 10, pp. 1944-1958, 2003.
52. K. A. J. M. VanDer Lee, P. H. M. Willemsen, G. J. VanDerVusse, and M. Van Bilsen, "Effects of fatty acids on uncoupling protein-2 expression in the rat heart, " The FASEB Journal, vol. 14, no. 3, pp. 495-502, 2000.
53. A. Planavila, I. Redondo-Angulo, F. Ribas et al., "Fibroblast growth factor 21 protects the heart from oxidative stress, " Cardiovascular Research, vol. 106, no. 1, pp. 19-31, 2015.
54. C. Perrino, G. G. Schiattarella, A. Sannino et al., "Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure, " Journal of the American Heart Association, vol. 2, no. 3, Article ID e000086, 2013.
55. A. Koziel, I. Sobieraj, and W. Jarmuszkiewicz, "Increased activity of mitochondrial uncoupling protein 2 improves stress resistance in cultured endothelial cells exposed in vitro to high glucose levels, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 309, no. 1, pp. H147-H156, 2015.
56. Y. Chen, J. Liu, Y. Zheng et al., "Uncoupling protein 3 mediates H2O2 preconditioning-afforded cardioprotection through the inhibition of MPTP opening, " Cardiovascular Research, vol. 105, no. 2, pp. 192-202, 2015.
57. A. Nègre-Salvayre, C. Hirtz, G. Carrera et al., "A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation, "TheFASEB Journal, vol. 11, no. 10, pp. 809-815, 1997.
58. A. Ruiz-Ramírez, M. Chávez-Salgado, J. A. Peñeda-Flores, E. Zapata, F. Masso, and M. El-Hafidi, "High-sucrose diet increases ROS generation, FFA accumulation, UCP2 level, and proton leak in liver mitochondria, " American Journal of Physiology-Endocrinology and Metabolism, vol. 301, no. 6, pp. E1198-E1207, 2011.
59. J. D. MacLellan, M. F. Gerrits, A. Gowing, P. J. S. Smith, M. B. Wheeler, and M.-E. Harper, "Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells, " Diabetes, vol. 54, no. 8, pp. 2343-2350, 2005.
60. S. Boudina, S. Sena, H. Theobald et al., "Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, " Diabetes, vol. 56, no. 10, pp. 2457-2466, 2007.
61. M. D. Brand, "The sites and topology ofmitochondrial superoxide production, " Experimental Gerontology, vol. 45, no. 7-8, pp. 466-472, 2010.
62. W. J. H. Koopman, F. Distelmaier, J. A. M. Smeitink, and P. H. G. M. Willems, "OXPHOS mutations and neurodegeneration, " The EMBO Journal, vol. 32, no. 1, pp. 9-29, 2013.
63. D. Robbins and Y. Zhao, "New aspects of mitochondrial uncoupling proteins (UCPs) and their roles in tumorigenesis, " International Journal of Molecular Sciences, vol. 12, no. 8, pp. 5285-5293, 2011.
64. M. Lagouge and N.-G. Larsson, "The role of mitochondrial DNAmutations and free radicals in disease and ageing, " Journal of Internal Medicine, vol. 273, no. 6, pp. 529-543, 2013.
65. V. G. Antico Arciuch, M. E. Elguero, J. J. Poderoso, and M. C. Carreras, "Mitochondrial regulation of cell cycle and proliferation, " Antioxidants & Redox Signaling, vol. 16, no. 10, pp. 1150-1180, 2012.
66. S. W. G. Tait and D. R. Green, "Mitochondria and cell signalling, " Journal of Cell Science, vol. 125, no. 4, pp. 807-815, 2012.
67. S. Orrenius, V. Gogvadze, and B. Zhivotovsky, "Mitochondrial oxidative stress: implications for cell death, " Annual Review of Pharmacology and Toxicology, vol. 47, pp. 143-183, 2007.
68. A. L. Sverdlov, A. Elezaby, F. Qin et al., "Mitochondrial reactive oxygen species mediate cardiac structural, functional, and mitochondrial consequences of diet-induced metabolic heart disease, " Journal of the American Heart Association, vol. 5, no. 1, Article ID e002555, 2016.
69. Y.-R. Chen and J. L. Zweier, "Cardiacmitochondria and reactive oxygen species generation, " Circulation Research, vol. 114, no. 3, pp. 524-537, 2014.
70. A. Ruiz-Ramírez, M.-A. Barrios-Maya, O. López-Acosta, D. Molina-Ortiz, and M. El-Hafidi, "Cytochrome c release from rat liver mitochondria is compromised by increased saturated cardiolipin species induced by sucrose feeding, " American Journal of Physiology-Endocrinology and Metabolism, vol. 309, no. 9, pp. E777-E786, 2015.
71. M. Schwarzer, M. Osterholt, A. Lunkenbein, A. Schrepper, P. Amorim, and T. Doenst, "Mitochondrial reactive oxygen species production and respiratory complex activity in rats with pressure overload-induced heart failure, " Journal of Physiology, vol. 592, no. 17, pp. 3767-3782, 2014.
72. T. Hang, Z. Huang, S. Jiang et al., "Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1, " Annals of Clinical and Laboratory Science, vol. 36, no. 1, pp. 88-95, 2006.
73. G. Condorelli, C. Morisco, G. Stassi et al., "Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat, " Circulation, vol. 99, no. 23, pp. 3071-3078, 1999.
74. I. G. Shabalina and J. Nedergaard, "Mitochondrial ('mild') uncoupling and ROS production: physiologically relevant or not?" Biochemical Society Transactions, vol. 39, no. 5, pp. 1305-1309, 2011.
75. R. J. Perry, D. Zhang, X.-M. Zhang, J. L. Boyer, and G. I. Shulman, "Controlled-releasemitochondrial protonophore reverses diabetes and protonophore reverses diabetes and steatohepatitis in rats, " Science, vol. 347, no. 6227, pp. 1253-1256, 2015.
76. F. E. Sluse, "Uncoupling proteins: molecular, functional, regulatory, physiological and pathological aspects, " Advances in Experimental Medicine and Biology, vol. 942, pp. 137-156, 2012.
77. Y. Chen, J. Liu, Y. Zheng et al., "Uncoupling protein 3 mediates H2O2 preconditioning-afforded cardioprotection through the inhibition of MPTP opening, " Cardiovascular Research, vol. 105, no. 2, pp. 192-202, 2015.
78. J. P. Brennan, R. G. Berry, M. Baghai, M. R. Duchen, and M. J. Shattock, "FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation, " Cardiovascular Research, vol. 72, no. 2, pp. 322-330, 2006.
79. G. Pucci, F. Battista, S. de Vuono et al., "Pericardial fat, insulin resistance, and left ventricular structure and function in morbid obesity, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 24, no. 4, pp. 440-446, 2014.
80. X. Sun, H. Pan, H. Tan, and Y. Yu, "High free fatty acids level related with cardiac dysfunction in obese rats, " Diabetes Research and Clinical Practice, vol. 95, no. 2, pp. 251-259, 2012.
81. A. S. Neitzel, A. N. Carley, and D. L. Severson, "Chylomicron and palmitate metabolism by perfused hearts from diabetic mice, " American Journal of Physiology-Endocrinology and Metabolism, vol. 284, no. 2, pp. E357-E365, 2003.
82. Y.-T. Zhou, P. Grayburn, A. Karim et al., "Lipotoxicheart disease in obese rats: implications for human obesity, " Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 97, no. 4, pp. 1784-1789, 2000.
83. M. Granér, R. Siren, K. Nyman et al., "Cardiac steatosis associates with visceral obesity in nondiabetic obesemen, " Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 3, pp. 1189-1197, 2013.
84. Y.-Q. Tian, S.-S. Li, X.-D. Su et al., "Effects of pioglitazone on high-fat-diet-induced ventricular remodeling and dysfunction in rats, " Journal of Cardiovascular Pharmacology andTherapeutics, vol. 17, no. 2, pp. 223-228, 2012.
85. A. Schrammel, M. Mussbacher, S. Winkler et al., "Cardiac oxidative stress in a mouse model of neutral lipid storage disease, " Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1831, no. 11, pp. 1600-1608, 2013.
86. A. N. Carley and D. L. Severson, "Fatty acid metabolism is enhanced in type 2 diabetic hearts, " Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1734, no. 2, pp. 112-126, 2005.
87. M. E. Young, P. H. Guthrie, P. Razeghi et al., "Impaired longchain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart, " Diabetes, vol. 51, no. 8, pp. 2587-2595, 2002.
88. L. Martínez, S. Torres, A. Baulies et al., "Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis, " Oncotarget, vol. 6, no. 39, pp. 41479-41496, 2015.
89. H. Gao, X.-J. Feng, Z.-M. Li et al., "Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides, " Archives of Biochemistry and Biophysics, vol. 565, pp. 76-88, 2015.
90. S. Wang, A. Subramaniam, M. A. Cawthorne, and J. C. Clapham, "Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle, " Diabetes, Obesity and Metabolism, vol. 5, no. 5, pp. 295-301, 2003.
91. M. A. Stavinoha, J.W. RaySpellicy, M. F. Essop et al., "Evidence for mitochondrial thioesterase 1 as a peroxisome proliferatoractivated receptor-α-regulated gene in cardiac and skeletal muscle, " American Journal of Physiology-Endocrinology and Metabolism, vol. 287, no. 5, pp. E888-E895, 2004.
92. R. Harmancey, H. G. Vasquez, P. H. Guthrie, and H. Taegtmeyer, "Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart, " The FASEB Journal, vol. 27, no. 10, pp. 3966-3978, 2013.
93. N. T. Boardman, T. S. Larsen, D. L. Severson, M. F. Essop, and E. Aasum, "Chronic and acute exposure of mouse hearts to fatty acids increases oxygen cost of excitation-contraction coupling, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 5, pp. H1631-H1636, 2011.
94. S. R. Costford, S. N. Chaudhry, S. A. Crawford, M. Salkhordeh, and M.-E. Harper, "Long-term high-fat feeding induces greater fat storage in mice lacking UCP3, " American Journal of Physiology-Endocrinology and Metabolism, vol. 295, no. 5, pp. E1018-E1024, 2008.
95. P. K. Mazumder, B. T. O'Neill, M. W. Roberts et al., "Impaired cardiac efficiency and increased fatty acid oxidation in insulinresistant ob/ob mouse hearts, " Diabetes, vol. 53, no. 9, pp. 2366-2374, 2004.
96. J. Y. Kong and S. W. Rabkin, "Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 282, no. 2, pp. H717-H725, 2002.
97. M. Murray, H. R. E. Dyari, S. E. Allison, and T. Rawling, "Lipid analogues as potential drugs for the regulation ofmitochondrial cell death, " British Journal of Pharmacology, vol. 171, no. 8, pp. 2051-2066, 2014.
98. M. Di Paola, T. Cocco, and M. Lorusso, "Arachidonic acid causes cytochrome c release from heart mitochondria, " Biochemical and Biophysical Research Communications, vol. 277, no. 1, pp. 128-133, 2000.
99. P. Schönfeld and L. Wojtczak, "Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport, " Biochimica et Biophysica Acta (BBA)-Bioenergetics, vol. 1767, no. 8, pp. 1032-1040, 2007.
100. E. L. Seifert, V. Bézaire, C. Estey, and M.-E. Harper, "Essential role for uncoupling protein-3 in mitochondrial adaptation to fasting but not in fatty acid oxidation or fatty acid anion export, " The Journal of Biological Chemistry, vol. 283, no. 37, pp. 25124-25131, 2008.
101. P. Schrauwen, J. Hoeks, G. Schaart et al., "Uncoupling protein 3 as a mitochondrial fatty acid anion exporter, " The FASEB Journal, vol. 17, no. 15, pp. 2272-2274, 2003.
102. K. S. Echtay, T. C. Esteves, J. L. Pakay et al., "A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling, " The EMBO Journal, vol. 22, no. 16, pp. 4103-4110, 2003.
103. M. D. Brand, R. Pamplona, M. Portero-Otín et al., "Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3, " Biochemical Journal, vol. 368, no. 2, pp. 597-603, 2002.
104. D. Dyntar, M. Eppenberger-Eberhardt, K. Maedler et al., "Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes, " Diabetes, vol. 50, no. 9, pp. 2105-2113, 2001.
105. D. B. Ostrander, G. C. Sparagna, A. A. Amoscato, J. B. McMillin, and W. Dowhan, "Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis, " Journal of Biological Chemistry, vol. 276, no. 41, pp. 38061-38067, 2001.
106. Y. Teshima, M. Akao, S. P. Jones, and E. Marbán, "Uncoupling protein-2 overexpression inhibitsmitochondrial death pathway in cardiomyocytes, " Circulation Research, vol. 93, no. 3, pp. 192-200, 2003.
107. M. Bosma, D.H. Dapito, Z. Drosatos-Tampakaki et al., "Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitromodel of cardiomyocyte lipotoxicity, " Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1841, no. 12, pp. 1648-1655, 2014.
108. D. P. Kelly, D. E. Hale, S. L. Rutledge et al., "Molecular basis of inheritedmedium-chain acyl-CoAdehydrogenase deficiency causing sudden child death, " Journal of Inherited Metabolic Disease, vol. 15, no. 2, pp. 171-180, 1992.
109. D.M. Kurtz, P. Rinaldo, W. J. Rhead et al., "Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15592-15597, 1998.
110. C. Pagano, A. Calcagno, M. Granzotto et al., "Heart lipid accumulation in obese non-diabetic rats: effect of weight loss, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 3, pp. 189-197, 2008.
111. J. Roussel, J. Thireau, C. Brenner et al., "Palmitoyl-carnitine increases RyR2 oxidation and sarcoplasmic reticulum Ca2+ leak in cardiomyocytes: role of adenine nucleotide translocase, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1852, no. 5, pp. 749-758, 2015.
112. J. Fauconnier, D. C. Andersson, S.-J. Zhang et al., "Effects of palmitate on Ca2+ handling in adult control and ob/ob cardiomyocytes: impact ofmitochondrial reactive oxygen species, " Diabetes, vol. 56, no. 4, pp. 1136-1142, 2007.
113. O. A. Alrob and G. D. Lopaschuk, "Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation, " Biochemical Society Transactions, vol. 42, no. 4, pp. 1043-1051, 2014.
114. M. D. Hirschey, T. Shimazu, E. Jing et al., "SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome, "Molecular Cell, vol. 44, no. 2, pp. 177-190, 2011.
115. S. S. Bharathi, Y. Zhang, A.-W. Mohsen et al., "Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site, " The Journal of Biological Chemistry, vol. 288, no. 47, pp. 33837-33847, 2013.
116. M. D. Hirschey, T. Shimazu, E. Goetzman et al., "SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation, " Nature, vol. 464, no. 7285, pp. 121-125, 2010.